Caplin Point Laboratories Ltd's injectables facility completes INVIMA audit successfully

INVIMA - Colombia conducted an inspection of the injectables facility of the Company located at Puducherry. The inspection was conducted between December 8th and 12th, 2025 and was completed successfully.

Commenting on the completion of the inspection Chairman Mr.C.C.Paarthipan added "the successful completion of INVIMA inspection at our injectables facility in Puducherry reinforces our commitment to expanding our reach in Latin America and delivering high-quality, affordable medicines to the patient population in this region. This is also an important milestone in our product strategy for our expansion into the larger Latin American market for specialty injectable products. It complements our already INVIMA approved Softgel section at the same site."

Shares of Caplin Point Laboratories Limited was last trading in BSE at Rs. 1962.65 as compared to the previous close of Rs. 1952.40. The total number of shares traded during the day was 3846 in over 496 trades.

The stock hit an intraday high of Rs. 1974.80 and intraday low of 1942.10. The net turnover during the day was Rs. 7538184.00.

Source : Equity Bulls

Keywords

CaplinPointLaboratories INE475E01026 Pharmaceuticals Puducherry InjectablesFacility INVIMA Colombia Inspection